VSI

Ventegra Announces the Successful Implementation of the New Ventegra Specialty Inclusion (VSI) Program

Retrieved on: 
Wednesday, May 1, 2024
Technology, Consulting, Professional Services, Health Insurance, Software, Practice Management, Managed Care, Pharmaceutical, Health, Data Management, Pharmacy, Probability, Safety, Explanation, Plasma protein binding, MBM, Pharming, MBA, Pharmacist, VSI

The VSI program underscores Ventegra’s clinical infrastructure and heritage as a company managed and operated predominantly by healthcare professionals, pharmacists, and certified pharmacy technicians.

Key Points: 
  • The VSI program underscores Ventegra’s clinical infrastructure and heritage as a company managed and operated predominantly by healthcare professionals, pharmacists, and certified pharmacy technicians.
  • Mark Shinmoto, Pharm.D., Chief Pharmacy Officer, says, “The Ventegra Specialty Inclusion (VSI) program’s capability is a vital and important new tool in Ventegra’s ability to appropriately manage the utilization of the plethora of drugs being brought to market.
  • Robert T. Taketomo, Pharm.D., MBA, President/CEO, explains, “The Ventegra Specialty Inclusion program reflects the clinical focus of Ventegra and our deep commitment to member care and managed care principles.
  • Unlike most traditional pharmacy benefit managers, Ventegra does not have any fiduciary commitment to shareholders and exists to serve and benefit its community.

Microchip Acquires ADAS and Digital Cockpit Connectivity Pioneer VSI Co. Ltd. to Extend Automotive Networking Market Leadership

Retrieved on: 
Thursday, April 11, 2024
Organization, Advanced driver-assistance system, Motion, System, Ecosystem, SDV, Safety, PCI Express, Risk, MCHP, Automotive industry, ADAS, Microchip Technology, 10-Q, Glass, BMW, Growth, GM, Acquisition, Ford, ASA, Data-rate units, Lidar, Stellantis, VSI, SerDes

The market size of automotive radar, camera and LiDAR modules is expected to grow by greater than two times between 2022 to 2028 to $27B in revenue, according to Yole Group1.

Key Points: 
  • The market size of automotive radar, camera and LiDAR modules is expected to grow by greater than two times between 2022 to 2028 to $27B in revenue, according to Yole Group1.
  • In response to these developments, the Automotive SerDes Alliance (ASA) was formed in 2019 and released the first open-standard ASA Motion Link (ASA-ML) specifications.
  • “Microchip Technology is an established and trusted market leader in automotive networking known for their automotive quality and robust supply chain, and our team is excited to join them to address the growing ADAS and digital cockpit connectivity market,” said Steve Kang, CEO of VSI Co. Ltd. “VSI is a leader in the development of ASA-ML products and was the first to introduce products to the market.
  • Stockholders of Microchip are cautioned not to place undue reliance on our forward-looking statements, which speak only as of the date such statements are made.

apoQlar enters into Collaboration with Mayo Clinic to Advance Patient Care with Extended Reality Technology

Retrieved on: 
Tuesday, March 12, 2024
XR, Education, VSI, Patient, Mayo Clinic, HIMSS, Health, Cancer, Environment

ORLANDO, Fla., March 12, 2024 /PRNewswire/ -- apoQlar, a pioneer in medical visualization technology, is excited to announce a collaboration with Mayo Clinic aimed at enhancing patient care through the innovative application of extended reality (XR) technology.

Key Points: 
  • ORLANDO, Fla., March 12, 2024 /PRNewswire/ -- apoQlar, a pioneer in medical visualization technology, is excited to announce a collaboration with Mayo Clinic aimed at enhancing patient care through the innovative application of extended reality (XR) technology.
  • Sirko Pelzl, CEO of apoQlar, shared his excitement about the collaboration, stating, "We aim to revolutionize patient care by incorporating cutting-edge XR technology into daily medical practices and workflows.
  • The use of XR technology in patient care is anticipated to offer extensive benefits, such as enhanced surgical planning, improved interdisciplinary team collaboration, and more effective patient education.
  • The collaboration will commence with a project dedicated to leveraging XR technology for developing personalized treatment plans within Mayo Clinic.

Procedural advice for orphan medicinal product designation: Guidance for sponsors

Retrieved on: 
Wednesday, April 3, 2024
Community, Reproduction, Letter, European Commission, European Communities, Inn, Patient, Agency, Translation, European Medicines Agency, Council, European, Deference, VSI, Marketing, Legislation, Certification, MHLW, Annex, European Economic Area, PDF, Public, Medication, Committee, Policy, Bibliography, EMA, CAT, COMP, SME, Language, Ministry, CHMP, Decision, Cisco Webex, Prevalence, Disease, Part, Classification, Regulation (European Union), Privacy, Commission, RTF, EEA, Sponsor, PMDA, FDA, Guideline, Diagnosis, Civil service commission, European Council, European Parliament, Recognition, Art, INN, Official Journal, Record, TEAMS, Mutual, Microsoft PowerPoint, ID, Pharmaceutical industry

Frequently asked questions ................................................................... 10

Key Points: 
    • Frequently asked questions ................................................................... 10

      Procedural advice for orphan medicinal product designation
      EMA/420706/2018

      Page 2/13

      1.

    • This Regulation lays down the procedure for
      the designation of medicinal products as orphan medicinal products and provides incentives for the
      development and placing on the market of designated orphan medicinal products.
    • The Regulation also
      establishes the Committee for Orphan Medicinal Products (COMP) within the European Medicines
      Agency (EMA), which is responsible for examining applications for orphan medicinal product
      designation.
    • As of 28 April 2000, the date this Regulation entered into force, sponsors have been able to
      submit applications for orphan medicinal product designation to the EMA.
    • Procedural advice for orphan medicinal product designation
      EMA/420706/2018

      Page 3/13

      2.

    • Objectives
      In examining an application for orphan medicinal product designation, the COMP will focus on
      determining whether the sponsor has established that the designation criteria are met, i.e.
    • To assist in the development of a policy on orphan medicinal products, an expert network will
      be built up by the Committee, with expert(s) identified as appropriate to be involved in the evaluation
      of applications for orphan medicinal product designation.
    • ?

      The complete application should include:

      Procedural advice for orphan medicinal product designation
      EMA/420706/2018

      Page 5/13

      Document

      Format

      General administrative and scientific information completed online via the portal.

    • Important:
      In preparing an application for orphan medicinal product designation, sponsors are requested to follow
      the Commission guideline (2022/C 440/02) on the format and content of applications for designation
      as orphan medicinal products.
    • Please refer to the Procedural advice on
      appeal procedure for Orphan Medicinal Product Designation (EMEA/2677/01 Rev.3).
    • The grounds for the

      Procedural advice for orphan medicinal product designation
      EMA/420706/2018

      Page 9/13

      appeal should be based only on the original information provided in the application for orphan
      designation.

    • ?

      The European Commission will enter the designated medicinal product in the Community Register
      of Orphan Medicinal Products.

    • General advice
      ?

      Full information on the procedure for orphan medicinal products designation is available on the
      EMA orphan designation website.

    • In accordance with Regulation (EC) No 141/2000 of 16 December 1999, the sponsor may submit an
      application for orphan medicinal product designation to the Agency at any stage of development of the

      Procedural advice for orphan medicinal product designation
      EMA/420706/2018

      Page 10/13

      medicinal product as long as the criteria for designation may be justified.

    • A request for orphan medicinal product designation may be made for
      a new orphan indication for an already authorised medicinal product.
    • Procedural advice for orphan medicinal product designation
      EMA/420706/2018

      Page 11/13

      Which are the sponsor?s options in case of negative outcome for orphan designation?

Badlands Ranch Announces Launch Within The Independent Pet Channel

Retrieved on: 
Tuesday, February 20, 2024
Pet, Animal, Dog, Ginger, Skin, Health, VSI, Digestion, ADMC, Partnership

PARK CITY, Utah, Feb. 20, 2024 /PRNewswire/ -- Badlands Ranch™, the premium dog nutrition brand providing superfood-packed dog food and treats for canine health, is excited to announce that the brand is now available to independent pet stores through its partnership with key distributors in the channel including Phillips Pet Food & Supplies, Veterinary Service Inc (VSI), American Distribution and Manufacturing Company (ADMC) and National Animal Nutrition, Inc (NAN).

Key Points: 
  • Founded by actress, animal advocate, and philanthropist Katherine Heigl, Badlands Ranch is an extension of her passion for animals, striving to enhance the lives of pets worldwide through unparalleled nutrition.
  • Badlands Ranch's dedication to pet well-being aligns seamlessly with the commitment to quality and community-building within the independent pet channel.
  • Part of the brand's commitment to pet well-being is the annual contribution of $250,000 to the Jason D Heigl Foundation to support the rescue and adoption of hundreds of pets in need.
  • "I am so excited to launch Badlands Ranch in independent pet stores and make our premium products accessible at local pet stores across the country," said Katherine Heigl, Founder of Badlands Ranch.

Fear Free and Antelligence Partner to Serve Veterinary Students

Retrieved on: 
Tuesday, January 9, 2024
Student, Partnership, VSI, Michigan State University, Medicine, Pet, History

DENVER, Jan. 9, 2024 /PRNewswire-PRWeb/ -- Fear Free® and Antelligence announced a partnership designed to help veterinary students better understand the business side of medicine, anchored by Fear Free's sponsorship of the Veterinary Student Insider (VSI), an Antelligence publication launched in 2021. The partnership is designed to expand VSI's reach and build its readership among students. It is also designed to promote and advance the student version of Fear Free, which is currently offered at no charge.

Key Points: 
  • Fear Free® and Antelligence announced a partnership designed to help veterinary students better understand the business side of medicine, anchored by Fear Free's sponsorship of the Veterinary Student Insider (VSI), an Antelligence publication launched in 2021.
  • DENVER, Jan. 9, 2024 /PRNewswire-PRWeb/ -- Fear Free® and Antelligence announced a partnership designed to help veterinary students better understand the business side of medicine, anchored by Fear Free's sponsorship of the Veterinary Student Insider (VSI), an Antelligence publication launched in 2021.
  • "We're thrilled to bring on Fear Free as a partner to serve students, promote Fear Free and greatly expand our reach into the student community," commented Dr. Bre Demaline, managing editor of the Veterinary Student Insider and a recent graduate of Michigan State University currently practicing in Michigan.
  • "Fear Free is excited to partner with Antelligence and sponsor the Veterinary Student Insider," said Randy Valpy, CEO of Fear Free.

Vinyl Institute Announces Recipients of Second Round of VIABILITY Grant Funding

Retrieved on: 
Wednesday, November 1, 2023
PVC, Electronic Industries Alliance, Fenestration, University of Florida, Engineering, Chemical industry, Organization, The Vinyl Institute, Research, AMA, VSI, CWC, University, Recycling, Green Eagles F.C., Plastic, Geography of Taiwan, Pharmaceutical industry

WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- The Vinyl Institute (VI), a U.S. trade association representing the leading manufacturers of vinyl, today announced its second round of funding to five organizations totaling nearly $330,000 through its VIABILITY™ recycling grant program. This brings the total dollar amount committed thus far to nearly $1 million – all thanks to generous contributions from four PVC resin producers (Formosa, Oxy, Shintech, and Westlake). The second round of VIABILITY recycling grant recipients include the University of Florida, Auto Mats & Accessories, Green Eagle, the Vinyl Siding Institute, and the Fenestration and Glazing Industry Alliance (FGIA).

Key Points: 
  • WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- The Vinyl Institute (VI), a U.S. trade association representing the leading manufacturers of vinyl, today announced its second round of funding to five organizations totaling nearly $330,000 through its VIABILITY™ recycling grant program.
  • The second round of VIABILITY recycling grant recipients include the University of Florida, Auto Mats & Accessories, Green Eagle, the Vinyl Siding Institute, and the Fenestration and Glazing Industry Alliance (FGIA).
  • "PVC recycling is real, and there is still room to continue growing our industry's capabilities," said Ned Monroe, president and CEO of the Vinyl Institute.
  • The VIABILITY grant program's goal is to accelerate post-consumer vinyl recycling to 160 million pounds by 2025.

Vinyl Institute Announces Recipients of Second Round of VIABILITY Grant Funding

Retrieved on: 
Wednesday, November 1, 2023
PVC, Electronic Industries Alliance, Fenestration, University of Florida, Engineering, Chemical industry, Organization, The Vinyl Institute, Research, AMA, VSI, CWC, University, Recycling, Green Eagles F.C., Geography of Taiwan, Plastic, Pharmaceutical industry

WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- The Vinyl Institute (VI), a U.S. trade association representing the leading manufacturers of vinyl, today announced its second round of funding to five organizations totaling nearly $330,000 through its VIABILITY™ recycling grant program. This brings the total dollar amount committed thus far to nearly $1 million – all thanks to generous contributions from four PVC resin producers (Formosa, Oxy, Shintech, and Westlake). The second round of VIABILITY recycling grant recipients include the University of Florida, Auto Mats & Accessories, Green Eagle, the Vinyl Siding Institute, and the Fenestration and Glazing Industry Alliance (FGIA).

Key Points: 
  • WASHINGTON, Nov. 1, 2023 /PRNewswire/ -- The Vinyl Institute (VI), a U.S. trade association representing the leading manufacturers of vinyl, today announced its second round of funding to five organizations totaling nearly $330,000 through its VIABILITY™ recycling grant program.
  • The second round of VIABILITY recycling grant recipients include the University of Florida, Auto Mats & Accessories, Green Eagle, the Vinyl Siding Institute, and the Fenestration and Glazing Industry Alliance (FGIA).
  • "PVC recycling is real, and there is still room to continue growing our industry's capabilities," said Ned Monroe, president and CEO of the Vinyl Institute.
  • The VIABILITY grant program's goal is to accelerate post-consumer vinyl recycling to 160 million pounds by 2025.

DR. MARTY PETS ANNOUNCES A NEW VARIETY OF THEIR BEST-SELLING NATURE'S BLEND DOG FOOD - RADIANT SELECT

Retrieved on: 
Thursday, August 24, 2023
VSI, Partnership, National Veterinary Services Laboratory, Pet, Overalls, Dicarboxylic acid, NAN, Tuna, Ginger, Amazon, ADMC, Salmon, Phillips, Dog, Growth, LOS, IPS, Health, Skin, Dietary supplement

LOS ANGELES, Aug. 24, 2023 /PRNewswire/ -- Dr Marty Pets™, the canine and feline brand offering cutting-edge, premium freeze-dried raw dog and cat food and supplements, is pleased to announce its new Nature's Blend Radiant Select dog food, a premium freeze-dried raw formula that is perfect for pups with dry skin and dull coats. The first five ingredients are pollock, beef heart, tuna, salmon, and beef liver, which are all rich in omega-3 fatty acids. These fatty acids are essential for maintaining healthy skin and a shiny coat.

Key Points: 
  • Nature's Blend Radiant Select contains delicious superfoods like flaxseed, apples, blueberries, cranberries, and ginger which are important for dogs' skin and coat health.
  • As with all of Dr. Marty Nature's Blend recipes, Radiant Select is made from whole foods only, meaning it is free of artificial vitamins & minerals, colors, and preservatives.
  • If you are looking for high-quality dog food to help your pup's skin and coat look their best, then Dr. Marty's Nature's Blend Radiant Select is the perfect choice.
  • *
    Dr. Marty Pets launched in the Independent channel over three years ago through a national partnership with Phillips Pet Supplies.

apoQlar secures funding led by YZR Capital, revolutionizes surgical care through partnerships

Retrieved on: 
Wednesday, July 5, 2023
VSI, Partnership, Microsoft HoloLens, Surgeon, National University Health System, MEC, Microsoft, Medicine, ASAP, Infocomm Media Development Authority, HoloLens 2, IMDA, NUHS, YZR, Architecture, 2.0, XR, Health, Cryptocurrency, Video game, Singtel

HAMBURG, Germany, July 5, 2023 /PRNewswire/ -- apoQlar, a pioneering healthtech company, has successfully secured a funding round led by venture capital firm YZR Capital, specializing in health tech investments.

Key Points: 
  • HAMBURG, Germany, July 5, 2023 /PRNewswire/ -- apoQlar, a pioneering healthtech company, has successfully secured a funding round led by venture capital firm YZR Capital, specializing in health tech investments.
  • The funding will be utilized to scale the new software release, VSI HoloMedicine® version 2.0, further improving surgical planning, medical education, and patient outcomes.
  • "We are thrilled to have received funding from YZR, a leading German venture capital firm in the healthtech space," said Sirko Pelzl, CEO and co-founder at apoQlar.
  • "This investment not only validates the potential of our augmented reality platform but also highlights the importance of our mission to improve surgical care.